Brachytherapy Afterloader

We are fervently committed to the provision of cancer care that is specifically designed to meet the unique needs of each patient.input:
output:The Elekta Xoft® Axxent® Electronic Brachytherapy (eBx®) System® was meticulously engineered to provide physicians with the utmost confidence in their ability to accurately and effectively treat cancer, thereby enabling patients to lead healthy, high-quality lives.input:
output:The Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a versatile treatment option that employs breakthrough electronic brachytherapy technology to offer a wider range of cancer treatments. Elekta Xoft enables the delivery of highly focused therapeutic radiation to the disease target in a minimally shielded environment, while simultaneously preserving the surrounding healthy tissue.input:
output:Elekta Xoft may not be accessible in all markets. A growing body of evidence supports the Xoft technology for the treatment of gynecological cancers, non-melanoma skin cancer (NMSC), and early-stage breast cancer. Colorectal, prostate, and pancreatic cancers are among the emerging applications. The numerous, valuable benefits that this innovative technology provides to patients, physicians, and health care institutions are the driving force behind our dedication to clinical excellence when utilizing it.input:
output:Brachytherapy is a term that refers to “near therapy,” which involves bringing the source of radiation in close proximity to the targeted tissue. The objective is to target the radiation dose to the cancerous area’s size and shape, while preserving healthy tissue and organs. This is in contrast to external beam, or linear accelerator technology, which administers treatment from outside the body.